Feng-Hsiu Su

Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection

Elizabeth G. Rhee, J. Newland, Julia D. Lonchar, 2023, The Pediatric infectious disease journal.

Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial

Elizabeth G. Rhee, E. Roilides, J. Bradley, 2023, The Pediatric infectious disease journal.

Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study

E. Asante-Appiah, T. Asselah, R. Talwani, 2019, Liver international : official journal of the International Association for the Study of the Liver.

1154. Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-abdominal Infection: A Phase 2, Randomized Clinical Trial

Elizabeth G. Rhee, J. Newland, Julia D. Lonchar, 2021, Open Forum Infectious Diseases.